Letter by Aw et al Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention"
- PMID: 29987115
- DOI: 10.1161/CIRCGEN.118.002253
Letter by Aw et al Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention"
Comment in
-
Response by Lee and Stouffer to Letter Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention".Circ Genom Precis Med. 2018 Jul;11(7):e002258. doi: 10.1161/CIRCGEN.118.002258. Circ Genom Precis Med. 2018. PMID: 29987116 No abstract available.
Comment on
-
Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.Circ Genom Precis Med. 2018 Apr;11(4):e002069. doi: 10.1161/CIRCGEN.117.002069. Circ Genom Precis Med. 2018. PMID: 29615454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
